Christian is a master’s student in the Porter Lab. He is studying prostate cancer progression and treatments. Here, he is sharing his experience in science and outreach at the University of Windsor. Presenting my poster at the Canadian Cancer Society’s IGNITE Summit. Hello all, here is what I’ve been up to: It was an honour to […]
In the spotlight – Christian Kassa Read More »
Sara Al-Noor, Tasneem Labak, Adam Bakos, Kaitlin Ferraro, Tejas Patel, Noah Cleary Tasneem Labak Glioblastoma (GBM) is the most common and lethal primary malignant brain cancer. Despite standard treatments, the average life expectancy is only about 15 months, and majority of patients experience recurrence of this aggressive cancer within a couple years of their initial
Interview With Dr. Lisa Porter: Advancing Breakthroughs in Cancer Research and Health Innovation Facebook X Email WhatsApp Reddit Print
Advancing Breakthroughs in Cancer Research and Health Innovation Read More »
Our names are Jeffery Martin and Vanessa Riolo, and we are the Porter lab’s Green Lab Ambassadors! Together with Dr. Fidalgo, our Green Lab representative, and Dr. Porter’s full support, we are very excited to share more about sustainability initiatives and the various steps our lab is actively taking to reduce our environmental impact and
From the Bench to Helping the Planet: Going Green for a Better Future Read More »
On average, one in three people is diagnosed with cancer in their lifetime. Almost everyone has felt its impact, whether personally or through family and friends. That shared reality gives cancer research a weight that is impossible to ignore. Over the years, I have seen how deeply the disease affects people, and those experiences quietly
Research, Collaboration, and the Path Toward Better Cancer Care Read More »
In my lab at the University of Windsor, my team has been investigating the role of the Spy1 (Speedy) protein, a cell-cycle regulator, in aggressive brain cancers like glioblastoma, one of the most aggressive and difficult-to-treat brain cancers. Our recent work has provided new insights into how Spy1 affects neural stem cells, which are critical
A Step Forward in Glioblastoma Research: What We’ve Learned About Spy1 in Stem Cells Read More »
My name is Jeffery Martin, and I am a second-year Master’s student working on the prostate cancer project in Dr. Porter’s lab in the Biomedical Science Department at the University of Windsor. In honour of Prostate Cancer Awareness Month, I would like to share some of the exciting prostate cancer research happening at the University
Groundbreaking Prostate Cancer Research at the University of Windsor Read More »
Christopher Jaworski Christopher Jaworski Glioblastoma (GBM) stands as one of the most lethal and aggressive brain cancers, often defying current treatment strategies. The outlook for patients remains grim, with average survival hovering around just 14 months after diagnosis. A major reason for this is the tumor’s ability to resist therapy and recur, often driven by
Stephanie Dinescu Glioblastoma (GBM) is the most frequent and aggressive primary malignant brain tumour. Despite rigorous therapeutic efforts, the prognosis of GBM remains extremely low, with a median survival of approximately 14 months after diagnosis. Our lab studies a cyclin-like protein called Spy1 which has been found to be elevated in GBM. Spy1 overrides cell-cycle checkpoints
Amy Llancari My project focuses on differentiating the progression of Non-alcoholic Fatty Liver Disease (NALFD) into Hepatocellular Carcinoma (HCC) between male and female mice. HCC is the sixth most prevalent cancer in the world, yet it ranks as the third leading type of cancer deaths with an accelerated increase in incidence rates. NAFLD is a
No position is available at the moment.
For interested graduate students please visit the University of Windsor Department of Biology for admission requirements (http://www1.uwindsor.ca/biology/graduate-program) and contact Dr Bre-Anne Fifield (fifield@uwindsor.ca) to express your interest in joining the lab.
For volunteers please contact Dr Dorota Lubanska (lubanskd@uwindsor.ca) and indicate the year you are in and the type of experience you are interested in. Note that interviews only happen once a year in the Spring.
Please click on the link below:
http://windsorcancerresearch.com/research/application-of-interest-in-cancer-research/